BTIG analyst Julian Harrison downgraded Apogee Therapeutics Inc (NASDAQ: APGE) from Buy to Neutral.The analyst comments "Following the APGE shareholder ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Downgrades